Notes archive.
Indus Infra Trust to buy Kerala highway for up to ₹1,000.84 cr
The trust is deploying fresh equity into a stabilised, toll-road asset with 14 years of annuity cash flows remaining.
Nis Management wins ₹15 cr Reliance renewal, 15% of its market cap
Seven Reliance entities renewed facility-management contracts with the nano-cap, securing revenue through March 2027.
Healthy Life Agritec's 66% revenue growth hides a cash crunch and audit red flags
Trade receivables tripled, swallowing cash from a recent raise. The auditor flagged unpaid taxes and management-only certifications.
Healthy Life Agritec's 66% sales jump masks auditor warnings and cash burn
Revenue grew 66% to ₹10,707 lakhs in FY26, but the auditor cited compliance gaps and operating cash flow turned deeply negative on ballooning receivables.
Muthoot Capital sells ₹85 cr in vehicle loans to steady the ship after profit crash
The nano-cap NBFC's second securitization this fiscal raises cash equal to 26% of its market cap, a critical liquidity step after a brutal earnings year.
Ather Energy's board meets June 12 with every fundraise option on the table
The EV maker will weigh equity, debt, or hybrid instruments. No target size or structure has been disclosed yet.
IFB Agro asks West Bengal's top bureaucrat to investigate its own excise department
The liquor maker has escalated a dispute with state authorities, seeking an independent probe into what it calls illegal interference.
Steelcast targets ₹100 cr profit, pulls forward capex decision
FY26 profit rose 20% to ₹87 cr. Management now wants to surpass ₹100 cr by FY27 and will decide on expansion by July.
Fino's loan referrals surge 186%. Its payments business keeps shrinking.
May data shows the bank's pivot to lending is accelerating, but at a steep cost to its original payments volume.
Government to sell up to 3% of NLC India for ~₹1,260 cr
The promoter's floor price of ₹303 a share implies a stake worth about ₹1,260 crore. The offer opens next week.
Suraj Estate tops ₹615 cr presales, borrows to buy more land
FY26 sales beat guidance by ₹15 crore. The developer used the earnings call to detail two land deals and a ₹580 crore debt load.
Him Teknoforge posts 29% profit growth. The news is it's not news.
The nano-cap auto-parts maker's press release reiterates already-disclosed FY26 results. Revenue rose 8% to ₹435.2 crore.
IFGL Refractories files its Q4 transcript. It adds nothing.
The verbatim record of the June 2 call is pure documentation. No new data, no revised guidance, no fresh commentary.
Shelter Pharma starts shipping ₹1.18 cr Sudan order
The nano-cap Ayurvedic maker has already dispatched USD 118,634 of the USD 141,600 order for Joemega Capsules, with the rest in transit.
GIC Re posts ₹8,392 cr profit but sees fire premiums softening
Net profit jumped 25% on a better combined ratio, but management flagged new domestic competition and a softening direct-fire market. Growth guidance for FY27 is just single-digit.
Dealmoney Commodities doubles down on Swojas Foods in two-month buying spree
A non-promoter's open-market purchases have lifted its stake to 14% in a nano-cap food processor where revenue is doubling but profits are falling.
Auditors disclaim opinion on Tirupati Innovar as trade balances explode
Chandabhoy & Jassoobhoy cannot verify ₹15,194 lakhs in receivables or the write-off of ₹14,746 lakhs in payables without documentation. Revenue surged 12x but profit fell.
Grasim will spend ₹3,094 cr to triple its Lyocell fibre capacity by 2030
The board approved two new 55,000-tonne lines at Harihar, taking total Lyocell capacity to 210,000 tonnes. The investment is 1.5% of market cap and won't hit earnings for years.
Panacea Biotec joins EU consortium to test dengue vaccine in Africa
The €11.1 million project will run Phase I/III trials of the single-dose DengiAll vaccine in sub-Saharan Africa. The grant goes to the consortium, not Panacea.
Tega's Molycop deal is live, but the growth outlook just got cut.
The $838M acquisition adds heavy debt to Tega's books. Management now sees Molycop growing at 3% in FY27, not the rate it expected.
TCPL's Q4 transcript is pure paperwork. The market already knew.
The call restates margin pressure from raw materials, export disruptions, and the ₹100 cr capex plan. No new numbers or guidance.
Kesar pulls in ₹21 cr from promoters as non-promoter warrants expire
Two promoter-group holders paid up on 1.5 crore warrants, bringing in ₹21.15 crore. Another 52 lakh warrants lapsed, forfeiting ₹2.44 crore in upfront money.
IFC has cut its Federal Bank stake by a quarter in seven months.
The World Bank's private-sector arm sold ₹14,400 crore of stock in multiple tranches between November 2024 and June 2025.
Vivo Bio Tech promoter sells 99% of its stake
Shri Shri Resorts cut its holding to 0.30% after dumping 10 lakh shares on the open market. The sale was about 4.5% of Vivo Bio Tech's market cap.
Rulka cuts debt 45%, now chasing ₹50-70 cr projects
FY26 revenue rose 38% to ₹110 cr and net profit jumped 46% to ₹3.29 cr. The ₹90 cr capital raise is to fund the pivot to bigger jobs.